Your Messages Inbox
Your Article Summary
See Latest ArticlesZila Completes First Phase of Global Marketing Initiatives for Oral Cancer Screening Product, ViziLite(R) Plus
Zila, 02/12/09
Zila, Inc. said it has completed the first phase of the global rollout for its proprietary oral cancer screening product, ViziLite Plus with TBlue. Beginning in North America and through its direct sales force, Zila now markets ViziLite Plus in all 50 states of the U.S., as well as Puerto Rico and Canada. Since May 2008, the company expanded to Western Europe by forming strategic alliances to distribute ViziLite Plus in a number of European markets.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor